Patriot Scientific der Highflyer 2006
Aber mit Hardware kann man kaum noch Geld verdienen, und in wie weit Komplettlösungen da Geld bringen, kann ich auch nicht einschätzen.
Trotzdem bleibt es spannend denn es gibt jetzt wieder ein neues "Eisen im Feuer", falls die Sache mit den Patenten schief gehen sollte.
Grüße Abenteurer
Sozusagen viel phantasie drin.
Aber 1 frage ich mich seit jahren.
Wen die Patente nicht gültig wären.Warum haben die unten aufgeführten unternehmen das Patent erworben?
deine vorstellung dazu?
MMP Portfolio Licensees
The following is a partial list of companies that have purchased licenses to the MMP portfolio:
AMD
Intel
Hewlett Packard
Fujitsu
Casio
Nikon
Sony
Seiko Epson
Pentax
Mattel
Emerson Radio
Audiovox
Olympus
Kenwood
Agilent
Schneider Electric
Lexmark
NEC
Funai Electric
SanDisk
Advanced Medical
Optics
Citizens Holding Co.
Sharp
Nokia
Bull
LEGO
DMP Electronics
Denso Wave
Philips
TEAC Corporation
Daewoo Electronics
Research in Motion
Onkyo Corporation
Lite-On
Alpine Electronics
Verigy
Humax
Psion PLC
Tokyo Electron
DirecTV
Gerber Scientific
WMS Gaming
The Bosch Group
Hoya Corporation
Crossflo Merger Posted by: patriotism on August 19, 2008 08:24AM Now we are in the final period before the closing of the Crossflo merger. Based on the deal structure, PTSC has to deliver shares to Crossflo at a value of $ 7.4 M (when I read the 8k 2 (i) section about the merger correctly, these shares will be transferred into an Escrow Account, where they remain over a period of one year, before they finally were issued to Crossflo). According to the 10k of PTSC, the company held 21,564,248 PTSC shares into treasury at the end of the fiscal year. Based on a shareprice of $ 0.25, these shares represent a current value of $ 5.39 M. If PTSC plans to deliver the whole volume from the stock into treasury to Crossflo, the company still must buy 8,035,752 shares at a price of $ 0.25 or the shareprice of PTSC must hit $ 0.34 during the closing period. I don't believe , that PTSC will gone buy 8 M shares during the closing period, because I think they only can buy back 10% of the monthly trading volume. But this seems nearly impossible, because I do believe the overall volume last month was too low. So there remain two possibilities for PTSC to deliver the agreed shares to Crossflo. First they can use a small portion of the preferred stock, but this would have a negative impact on the future freefloat of the company. And the second chance I see is to start a promotion accompanied by several pressreleases of the company over the next days to move the shareprice up. Additionally PTSC should -get the traders on board -contact the managers of the quantservers and ask them to let the "b-program" run temporarely on the machines -inform S not to dump shares into a possible runup and to support PTSC -use the current shareholders to support PTSC -share buy back of PTSC Under these circumstances I see a possibility to reach the needed target price. The Holocom news from today can be start, but IMHO we need one more license, a letter to shareholders and an update on the Software acquisition or anything else, that can provide a higher valuation. PA Crossflo Merger Posted by: Patriotismus im August 19, 2008 08:24 AM
Schön ins deutsche Übersetz .
Kommentare sind willkommen
@ abenteuer: Wenn die Patente nicht gültig wären.Warum haben die unten aufgeführten unternehmen das Patent erworben?
deine vorstellung dazu?
Nun sind wir in der letzten Zeit vor der Schließung der Crossflo Fusion. Basierend auf den Deal-Struktur, PTSC hat zur Abgabe von Aktien an Crossflo auf einen Wert von $ 7,4 Millionen (wenn ich lese die 8k 2 (i) Abschnitt über die Fusion richtig, diese Aktien werden zu einem Escrow-Konto, wo sie bleiben über einen Zeitraum von einem Jahr, bevor sie schließlich wurden ausgestellt Crossflo). Nach den 10k von PTSC hat das Unternehmen im Besitz 21564248 PTSC Aktien in Schatzkammer am Ende des Geschäftsjahres. Basierend auf einer Shareprice von $ 0,25, diese Aktien repräsentieren einen aktuellen Wert von $ 5,39 M. Wenn PTSC Pläne zu liefern das gesamte Volumen aus dem Lager in die Staatskasse um Crossflo, das Unternehmen kaufen müssen noch 8035752 Aktien zu einem Preis von $ 0,25 oder die Shareprice von PTSC müssen hit $ 0,34 während der Schliessung Zeitraum. Ich glaube nicht, dass PTSC wird gegangen kaufen 8 M Aktien während der Schliessung, weil ich denke, sie kann nur Rückkauf 10% der monatlichen Handelsvolumen. Aber das scheint fast unmöglich, weil ich glaube das Gesamtvolumen im vergangenen Monat war zu niedrig.
Also bleiben zwei Möglichkeiten für PTSC zur Erbringung der vereinbarten Aktien an Crossflo. Erstens können sie einen kleinen Teil der Vorzugsaktien, aber dies hätte negative Auswirkungen auf die Zukunft Streubesitz des Unternehmens.
Und die zweite Chance sehe ich darin, eine Promotion begleitet von mehreren presseinformationen des Unternehmens über die nächsten Tage, um die Shareprice. Zusätzlich sollte PTSC
- get die Händler an Bord -
wenden Sie sich an den Managern der quantservers und sie bitten, damit sich die "B-Programm" run temporarely auf den Maschinen S-Inform nicht zu dumpen Aktien in einer möglichen Vorfeld und zur Unterstützung von PTSC -
Verwendung der aktuellen Aktionäre unterstützen PTSC Aktien-Rückkauf von PTSC Unter diesen Umständen sehe ich eine Möglichkeit zur Erreichung des Ziels erforderlich.
Die Holocom Nachrichten von heute kann beginnen, aber IMHO brauchen wir eine weitere Lizenz, einen Brief an die Aktionäre und ein Update auf die Software Anschaffungs-oder irgendetwas anderes, das kann eine höhere Bewertung.
Crossflo Merger Posted by: patriotism on August 19, 2008 08:24AM Now we are in the final period before the closing of the Crossflo merger. Based on the deal structure, PTSC has to deliver shares to Crossflo at a value of $ 7.4 M (when I read the 8k 2 (i) section about the merger correctly, these shares will be transferred into an Escrow Account, where they remain over a period of one year, before they finally were issued to Crossflo). According to the 10k of PTSC, the company held 21,564,248 PTSC shares into treasury at the end of the fiscal year. Based on a shareprice of $ 0.25, these shares represent a current value of $ 5.39 M. If PTSC plans to deliver the whole volume from the stock into treasury to Crossflo, the company still must buy 8,035,752 shares at a price of $ 0.25 or the shareprice of PTSC must hit $ 0.34 during the closing period. I don't believe , that PTSC will gone buy 8 M shares during the closing period, because I think they only can buy back 10% of the monthly trading volume. But this seems nearly impossible, because I do believe the overall volume last month was too low. So there remain two possibilities for PTSC to deliver the agreed shares to Crossflo. First they can use a small portion of the preferred stock, but this would have a negative impact on the future freefloat of the company. And the second chance I see is to start a promotion accompanied by several pressreleases of the company over the next days to move the shareprice up. Additionally PTSC should -get the traders on board -contact the managers of the quantservers and ask them to let the "b-program" run temporarely on the machines -inform S not to dump shares into a possible runup and to support PTSC -use the current shareholders to support PTSC -share buy back of PTSC Under these circumstances I see a possibility to reach the needed target price. The Holocom news from today can be start, but IMHO we need one more license, a letter to shareholders and an update on the Software acquisition or anything else, that can provide a higher valuation. PA Crossflo Merger Posted by: Patriotismus im August 19, 2008 08:24 AM
agoracom.com/ir/patriot/messages/914175#message
Nun sind wir in der letzten Zeit vor der Schließung der Crossflo Fusion. Basierend auf den Deal-Struktur, PTSC hat zur Abgabe von Aktien an Crossflo auf einen Wert von $ 7,4 Millionen (wenn ich lese die 8k 2 (i) Abschnitt über die Fusion richtig, diese Aktien werden zu einem Escrow-Konto, wo sie bleiben über einen Zeitraum von einem Jahr, bevor sie schließlich wurden ausgestellt Crossflo). Nach den 10k von PTSC hat das Unternehmen im Besitz 21564248 PTSC Aktien in Schatzkammer am Ende des Geschäftsjahres. Basierend auf einer Shareprice von $ 0,25, diese Aktien repräsentieren einen aktuellen Wert von $ 5,39 M. Wenn PTSC Pläne zu liefern das gesamte Volumen aus dem Lager in die Staatskasse um Crossflo, das Unternehmen kaufen müssen noch 8035752 Aktien zu einem Preis von $ 0,25 oder die Shareprice von PTSC müssen hit $ 0,34 während der Schliessung Zeitraum. Ich glaube nicht, dass PTSC wird gegangen kaufen 8 M Aktien während der Schliessung, weil ich denke, sie kann nur Rückkauf 10% der monatlichen Handelsvolumen. Aber das scheint fast unmöglich, weil ich glaube das Gesamtvolumen im vergangenen Monat war zu niedrig. Also bleiben zwei Möglichkeiten für PTSC zur Erbringung der vereinbarten Aktien an Crossflo. Erstens können sie einen kleinen Teil der Vorzugsaktien, aber dies hätte negative Auswirkungen auf die Zukunft Streubesitz des Unternehmens. Und die zweite Chance sehe ich darin, eine Promotion begleitet von mehreren presseinformationen des Unternehmens über die nächsten Tage, um die Shareprice. Zusätzlich sollte PTSC - get die Händler an Bord - wenden Sie sich an den Managern der quantservers und sie bitten, damit sich die "B-Programm" run temporarely auf den Maschinen S-Inform nicht zu dumpen Aktien in einer möglichen Vorfeld und zur Unterstützung von PTSC - Verwendung der aktuellen Aktionäre unterstützen PTSC Aktien-Rückkauf von PTSC Unter diesen Umständen sehe ich eine Möglichkeit zur Erreichung des Ziels erforderlich. Die Holocom Nachrichten von heute kann beginnen, aber IMHO brauchen wir eine weitere Lizenz, einen Brief an die Aktionäre und ein Update auf die Software Anschaffungs-oder irgendetwas anderes, das kann eine höhere Bewertung.
www.wallstreet-online.de/diskussion/...gt-gegen-intel#neuster_beitrag
Kontra: Es gibt verschiedene Theorien warum die Firmen zahlen - unter anderem eben die, dass es sich für kleine Firmen nicht lohnt sich auf einen Rechtsstreit einzulassen, wenn die Lizenz nur 'ne schlappe Million kostet.
Pro: Bei großen Firmen kann man davon ausgehen, dass die Rechtsabteilung die Patente auf Gültigkeit geprüft hat.
Fazit: Wenn die Kosten der Lizenz den eines Gerichtsstreits überschreiten, dann trifft man sich vor Gericht - haben wir ja so erlebt.
Trotzdem, bleibt es die Entscheidung des Patentamts und die kann so oder so ausfallen. Um so wichtige für eine Firma wie PTSC sich nach weiteren Einnahmequellen umzusehen.
Posted by: Mark4321 on August 19, 2008 11:39AM
They indicate they are improvements on that patent. Actually, I think they are request to file new applications. Some have been approved.
Inventors: George W. Shaw, Martin G. McClurg, Bradley D. Jensen, Russell H. Fish, Charles H. Moore
USPTO Application #: 20080091920 - Class: 712202000 (USPTO)
Related Patent Categories: Electrical Computers And Digital Processing Systems: Processing Architectures And Instruction Processing (e.g., Processors), Architecture Based Instruction Processing, Stack Based Computer
The Patent Description & Claims data below is from USPTO Patent Application 20080091920.
For some reason they only show George W. Shaw name but they refer to the Sh-Boom chip and patent # 5440749
09/051263
11/981482
11/981453
11/981237
11/981278
11/881283
11/881284
They all relate to the RISC chip technology. The type chips that ARM has made their speciality. Also most of today's fast chips are RISC style.
Please, check it out with RG or with shareholders relations. I would like to know for sure if it is our patent applications or did we sell / trade something that gave Shaw our rights to improve on the 749 patent. PTO wrapper show some transaction took place in Aug, 2008
IMO
GLTAL
photos.imageevent.com/banos/uspto/148%20Examiner%20Intervw%20Summry%20Record%207%2030%2008.pdf
ganz wichtig zu beobachten,das nur noch die claims 4 und 8 in untersuchung sind.
ich gehe stark davon aus,das bis zum SHM alles geklärt sein müsste.
Denn Goerner wird min 1 überraschung im ärmel haben müssen.
Patriot Scientific Corporation Engages Imperial Capital, LLC to Assist in M&A Efforts
CARLSBAD, Calif.--(BUSINESS WIRE)--Patriot Scientific Corporation (OTCBB:PTSC) today announced that it has engaged Imperial Capital, LLC., Los Angeles, Calif., as its financial advisor to assist the Company in identifying, and negotiating, potential acquisition targets and to provide general financial advisory services related to possible future acquisitions.
Previously Patriot Scientific announced a plan to expand its business base beyond its successful IP licensing model, into an operating company focused on such technologies as software, networking and wireless. Patriot Scientific has already announced three transactions this fiscal quarter and continues to target opportunities in the data sharing and secure data solutions markets. Earlier this month, Patriot announced it had completed a definitive agreement to acquire Crossflo Systems Inc, a San Diego based provider of innovative data sharing software for healthcare, law enforcement, government agency and other corporate applications.
“Engaging Imperial Capital, an investment banker with unique insights into the security solutions sector, will help Patriot Scientific focus on a broader range of synergistic targets for our merger and acquisition efforts,” said Rick Goerner, Patriot Scientific President and CEO. “We are building a business model on data sharing and secure data solutions,” he added. “Engaging an investment banker at this juncture legitimizes our broader M&A efforts and allows us to target larger opportunities, including public companies.”
Patriot Scientific plans to use the cash generated from its IP portfolio to acquire, or otherwise invest in technology companies that further its vision of secure data sharing in a connected world. In its recently released Form 10-K report to the SEC, Patriot reported nearly $20 million in cash and marketable securities with no debt.
Alle einzelteile werden erkannt und zusammengesetzt.
Goerner,super arbeit.. Weiter so.
Ich will den $ sehen ,vor dem SHM noch
http://www.imperialcapital.com/ProductsServices/Coverage.aspx
Bankruptcy / Litigation / Liquidation
Adelphia Communications Corp. Interstate Bakeries Corp.
Calpine Corporation Iridium LLC
Calpine Generating Corp. Mirant Corp.
Collins & Aikman Nationsrent, Inc.
Congoleum Corp. Northwestern Corporation
Dana Corp. Pope & Talbot
Delta Airlines, Inc. RSL Communications
DVI Liquidation Tower Automotive, Inc.
Federal Mogul TXU Europe Stub
Fleming Companies Winstar
Friede Goldman Halter, Inc. WR Grace
Global Power Equipment
High-Yield & Distressed Debt
Retail
Anvil Knitwear Dollar General Corp.
Blockbuster Inc. Movie Gallery, Inc.
Broder Bros. OSI Restaurants
Buffets Sbarro, Inc.
Burlington Coat Factory Uno Restaurants
Checkers Drive-In Vicorp
Claire's Stores Yankee Candle
Consumer Products
Amscan Holdings North Atlantic Trading Co.
Eurofresh Revlon, Inc.
Henry Company Solo Cup Co.
Interactive Health LLC WKI Holdings, Inc.
Leiner Health
Housing-related
Technical Olympic Realogy Corp.
Ainsworth Lumber MAAX Corp.
Land Source Masonite Corp.
SIRVA Owens Corning
Telecom
Charter Communications Metromedia International Group, Inc.
ICO Global Communications (Holdings) Ltd. Pacific Crossing Ltd.
ION Media Pappas
iPCS, Inc. Primus Telecommunications Group, Inc.
ITC^Deltacom, Inc. Satmex
Level 3 XO Holdings
Media
Haights Cross Comm.
Sun Times Media Group
Automotive
Dura Automotive Delphi Automotive
Hayes Lemmerz International, Inc. Remy International
Metaldyne Key Plastics
Plastech
Gaming
155 Tropicana East (Hooters) Herbst Gaming
French Link Resort & Casino Magna Entertainment
Industrials
Keystone Consolidated Exide Technologies
EaglePicher Inc. Mississippi Phosphates Corp.
Manufacturing
Generac Wolverine Tube, Inc.
Packaging
Constar International Portola Packaging, Inc.
Graham Packaging
Printing
American Color Graphics Vertis Inc.
Oil & Gas
CDX Gas Trident Exploration
Technology
MagnaChip Semiconductor LLC Freescale Semiconductor
Miscellaneous
Bally Total Fitness Atlantic Express
Premier Dental (Western Dental) IdleAire Technologies Corporation
Performant Financial Corporation Wellman, Inc.
Scotia Pacific Company, LLC
Busted Converts
Advanced Micro Devices, Inc. Jazz Technologies, Inc.
Antigenics, Inc. Magna Entertainment Corp.
Atherogenics, Inc. Merix Corp.
Cell Genesys, Inc. Nabi Biopharmaceuticals
Cell Therapeutics, Inc. Oscient Pharmaceuticals Corp.
Credence Systemps Corp. Overstock.com, Inc.
CuraGen Corp. Palm Harbor Homes, Inc.
deCODE genetics Inc. Pier 1 Imports, Inc.
Eddie Bauer Holdings, Inc. Pixelworks, Inc.
Empire Resorts, Inc. Primus Telecommunications Group, Inc.
Encysive Pharmaceuticals, Inc. Rewards Network, Inc.
Endeavor International Corp. Standard Motor Products, Inc.
Exide Technologies Standard Pacific Corp.
FiberTower Corporation Trex Co. Inc.
ICO Global Communications (Holdings) Ltd. UTStarcom, Inc.
Impax Laboratories, Inc. Vion Pharmaceuticals, Inc.
Isolagen, Inc. WCI Communities, Inc.
Equities
American Greetings Corp. Orbcomm Inc.
Ballantyne of Omaha Ormet Corp.
Brookfield Homes Corp. Parlux Fragrances
Delphi Automotive Point Bank Solutions
Eddie Bauer Holdings PRG-Schultz International
EnPro Industries, Inc. RTI International Metals
Famous Dave's Sevan Marine ASA
Foamex International, Inc. Source Interlink Companies, Inc.
Footstar Inc. Texas Petrochemicals
Foster Wheeler Ltd. Thermadyne
Friedman, Billings, Ramsey Group, Inc. Titan International
GeoEye Trico Marine Services, Inc.
Hawaiian Holdings, Inc. TRM Corporation
Immersion Wagon plc
Ivernia Inc. Xanadoo Company
Jones Apparel Group Zale Corp.
Measurement Specialties Zilog, Inc.
Northern Offshore Ltd. Zoltek Companies, Inc.
Letter to Shareholders
2008-07-21
......Following last month’s announcement of the signing of a non-binding MOU, we have continued to make progress in both due diligence and in the negotiation of a definitive agreement, in our efforts to acquire a differentiated software provider. If we are successful, I expect to announce the completion of the transaction by the end of September. We believe this transaction will provide synergy to other activities that Patriot is pursuing........
Additionally, we expect to engage an investment banker in the next month t
We have identified three other "companies of interest" that would require the services of an investment banker.
o help expand the list of opportunities for M&A and to facilitate future M&A transactions by providing guidance and advice concerning deal value, structure and integration strategies.
News 2008-08-20
Patriot Scientific Corporation (OTCBB:PTSC - News) today announced that it has engaged Imperial Capital, LLC., Los Angeles, Calif., as its financial advisor to assist the Company in identifying, and negotiating, potential acquisition targets and to provide general financial advisory services related to possible future acquisitions.
.........
Rick Goerner, Patriot Scientific President and CEO. "We are building a business model on data sharing and secure data solutions," he added. "Engaging an investment banker at this juncture legitimizes our broader M&A efforts and allows us to target larger opportunities, includung public companies.
Excellent job Mr. Goerner!
The new financial advisor will support PTSC
-to close the Crossflo deal in the next days
-to finalize the possible acquisition of a differientiated software provider by the end of September
-to prove an investment in the three identified other comanies of interest, that would require the services of an investment banker
-to target larger opportunities including public companies
If the available internet informations about Crossflo are true, PTSC could book annually $ 20 M in own revenues from that acquisition +x beginning in September. Assuming, that the recently announced large orders of Holocom and the growing demand for the Holocom products will lead to an additional huge growth in the next 12 months, Patriot overall could recognize own revenues of $ 27 M + 37% of the first initial revenues of Talis to be expected beginning by the end of the year and maybe upcoming additional revenues in the months thereafter. The upcoming annual meeting could become very interesting this year and I hope, that some more financial details and projections/forecasts about future revenues and income from these transactions will be issued at this time. The pressrelease about the closed merger with Crossflo could be a perfect moment to release the revenues 2007, employees, software licensing models, anticipated growth, net profit 2007 of this company.
PS: Let the next licensees come...
PA
Merkwürdig ist die Kursentwicklung, da alle wegen der Crossflow-Vereinbarung mit steigenden Kursen gerechnet haben. Tatsächlich fällt der Kurs bei minimalen Umsätzen.
Hat jemand eine Erklärung dafür ?
P.S. Gegen den Dollar habe ich nichts, aber 2-3 Dollar wären besser.
Letter to Shareholders from Patriot Scientific Corporation President/CEO Rick Goerner Updates Future Business Strategies
Wednesday August 20, 7:00 pm ET
CARLSBAD, Calif.--(BUSINESS WIRE)--To all shareholders and stakeholders of Patriot Scientific Corporation (OTCBB: PTSC - News), this letter provides an update on significant business activities at the Company. It has been my intention these past six months to facilitate regular communication to Patriot Scientific’s shareholders through these letters to provide insight on topical issues and to provide a uniform status report on important activities at the Company.
In this letter I focus on three topics: 1) an update on activities to expand Patriot Scientific’s future business prospects, 2) an update on our plan to improve Patriot Scientific’s investor relations (IR) and public relations (PR) program, and 3) comments on questions received from shareholders.
Patriot’s 2008 10-K results
As in prior letters, I won’t go through the extensive details contained in the Company’s report on Form 10-K that was filed with the SEC on August 14, 2008. Patriot Scientific’s balance sheet remains strong with no debt and a strong cash position. When considering Patriot Scientific’s results, it is important to point out that the Company paid almost $12 million more in income taxes in fiscal 2008 compared to 2007 due to the expiration of net operating loss carry-forwards, and we still held over $19 million in cash and marketable securities at fiscal year end. Having cash in this market is a significant advantage as Patriot Scientific assesses, and attracts, M&A opportunities. SSDI also demonstrated positive progress with expanded revenues and profitable results for the year.
Through May 31st, total MMP™ Portfolio licenses exceeded $240 million with TPL/Alliacense continuing to close new MMP™ licenses, announcing 27 new licensees in Patriot Scientific’s fiscal 2008.
Positioning Patriot Scientific for the future
This past month has been particularly busy with activities including finalizing the details of our announced acquisition of Crossflo Systems, Inc., increasing Patriot Scientific’s stake in Talis Data Systems, and continuing to assess several new opportunities.
Patriot Scientific has begun to focus on data sharing and secure data networking technology with a bias toward software companies with synergistic software modules that complement a complete secure data sharing solution for potential customers in healthcare, law enforcement and government agency applications. The following updates activities in the three areas we have identified to expand our revenues.
1. Selective expansion of Patriot Scientific's IP portfolio to build on the future revenues of the MMP(TM) Portfolio:
Recent MMP(TM) portfolio license announcements with Hoya Corporation, Robert Bosch and Audiovox evidence the global efforts of the TPL/Alliacense licensing activity.
We have made progress on Patriot Scientific's agreement with NuPOWER Semiconductor to validate the NUSEM IP at customers needing to improve the performance, accuracy and efficiency of next generation power management architectures. We have made initial contacts with customers, set customer meetings and outlined the business model for new licensees. We believe that NuPOWER's technology can help Patriot Scientific develop an on-going royalty revenue stream.
Also in the area of IP expansion, we have held preliminary discussions with the developers of advanced networking IP technology for Digital Subscriber Line (DSL) applications.
2. Pursue minority investments, undertaken as a strategic investor, in certain early-stage revenue or technology ventures that represent a future technology or capability of interest to Patriot Scientific:
Effective August 1, Patriot Scientific increased its stake in Talis Data Systems by acquiring all Talis shares held by SSDI and certain other minority shareholders, while also making an additional direct cash investment furthering our position in Talis. After a subsequent cash investment from Talis employees and other investors, our resultant ownership now stands at 37%. Talis pre-production samples of its Datagent multi-domain hardware have now passed testing and design validation, with customer sample units being released for assembly and expected to be available late next month. As reported last month, Talis projects initial revenues later this year through an expanding network of integration partners such as Synnex and Arrow.
Patriot Scientific has made progress in its due diligence efforts to validate the technology, and business assumptions, to acquire, for cash, nearly 20% of a Silicon Valley developer of mobile networking software to facilitate the transfer of video content to mobile devices. We are on track to complete the transaction by the end of August. Industry projections indicate that video-enabled handsets will increase from under 5% today to more than 70% by 2011. We believe this company has differentiated technology and has recently contracted field trials with several major international carriers that will be launched before the end of 2008. Recently the company demonstrated its ability to download its software at an Asian carrier, going online within one day.
3. Full M&A opportunities:
We continue to make progress towards obtaining Crossflo shareholder approvals, and other details required to close the transaction by September 1st. We believe that Crossflo will serve as a core capability for other software activities that Patriot Scientific is pursuing with a focus on "data sharing and secure data solutions for a connected world."
Additionally, we announced today that Patriot Scientific has engaged Imperial Capital, LLC as our investment banker to help expand the list of opportunities for M&A and to facilitate future M&A transactions by providing guidance and advice concerning deal value, structure and integration strategies. In addition to the above activities, Imperial will initiate contact with several public "companies of interest".
We have held numerous meetings with several other companies that have healthcare, data security, data extraction and analysis products that can complement the core Crossflo technology.
While we are confident about our progress to close our transaction with Crossflo and to make continued progress on other opportunities, we need to remember that the acquisition process can be both complicated and time consuming, and there can be “false starts” resulting in no completed transaction as a consequence of the due diligence review, failure to close on key terms of the definitive agreement, changes in the business conditions of either company and other factors.
Improving investor relations (IR) and public relations (PR)
We have begun handling all shareholder inquiries in-house. Initial shareholder feedback has been very positive. We expect that moving shareholder communications in-house will continue to improve responsiveness, and the quality of response, to shareholder inquiries.
Ibis Consulting Group took over Patriot Scientific’s outbound IR efforts effective August 1, 2008. Ibis will be responsible for driving a more proactive investor relations program aimed at new equity fund investors, both in the US and globally. Ibis has a strong track record of success dealing with companies, like Patriot Scientific, to introduce the Company to new equity investors that can make a positive difference in our future. I was in New York City this past month meeting with several existing and new equity investors to discuss Patriot Scientific’s vision for the future. Ibis is coordinating subsequent meetings through year-end, including several industry conferences. These venues represent an opportunity to outline the strength of the Patriot transition story. We will have more information on these conferences as details become available.
We are also planning to post an updated Patriot Scientific business overview on the Company’s website next week for investor review and comment. It outlines our vision for Patriot Scientific’s future, leveraging the success of the MMP™ licensing efforts, into data sharing and secure data solutions.
We have begun planning for our shareholder meeting to be held in Carlsbad, CA on October 30, 2008. I will provide more details regarding the meeting and key shareholder initiatives in my next letter.
I want to reiterate that it is my objective to continually improve the quality, uniformity and responsiveness of our communications to shareholders and the marketplace, and I will continue to look forward to your comments and inquiries.
Comments on other shareholder inquiries
Recent shareholder inquiries, generally, fall into the following categories:
1) Business details regarding the Crossflo Systems, Inc acquisition
2) Update on USPTO actions on MMP(TM) patent re-examinations
3) Update on Auction Rate Securities (ARS)
1) Business details regarding the Crossflo Systems, Inc acquisition
We expect to close the Crossflo acquisition by September 1, 2008. It would be inappropriate to disclose any financial and business details of Crossflo’s business until the transaction is finalized. We expect to have a Crossflo overview as part of Patriot Scientific’s upcoming shareholder meeting and plan to file audited historical financial statements for Crossflo with the SEC in early October.
2) Update on USPTO actions on MMP™ patent re-examinations
The patent re-examination process is a very complicated and lengthy process. Both Patriot Scientific and TPL are involved in the litigation regarding the patents, and comments regarding the status of the various patent re-examinations cannot be made. We look forward to the final actions by the USPTO. TPL/Alliacense continues to be active as evidenced by new MMP™ licensees.
3) Update on Auction Rate Securities (ARS)
There has been much press coverage recently on the ARS situation. Merrill Lynch, Citigroup and UBS have recently announced plans to redeem their ARS, and we are encouraged by the actions of the government and the banking institutions to resolve this widespread issue. As we understand the terms of these announced arrangements, for now they only address ARS held by retail customers, and then only on a protracted buy-out schedule. Although Patriot Scientific’s exposure to its ARS position was reduced in April, we still hold $12.9 million of these instruments. In response to this situation, we have negotiated access to cash collateralized by the ARS with an institutional lender in the event we need access to additional capital. Our current cash forecasts do not project a need to access the funds secured by the ARS.
I trust this letter has provided you with additional information regarding the status of key business initiatives at Patriot Scientific. Please feel free to send us your comments and any additional questions. We are making measurable progress with respect to our stated goals. I look forward to your support as we transition ahead and remain excited about the opportunity to build a strong future for Patriot Scientific.
Sincerely,
Rick Goerner
President/CEO
Patriot Scientific Corporation
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Moore Microprocessor Patent (MMP) and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC is a trademark of Patriot Scientific Corporation. All other trademarks belong to their respective owners.
Contact:
Patriot Scientific
Paul Bibeau, 760-547-2700
Source: Patriot Scientific Corporation
Our current cash forecasts do not project a need to access the funds secured by the ARS.
CARLSBAD, Calif., Aug 21, 2008 (BUSINESS WIRE) -- Patriot Scientific Corp. (OTCBB: PTSC) today announced that the Roland Corporation has purchased a Moore Microprocessor Patent(TM) (MMP) Portfolio license from The TPL group, Patriot Scientific's exclusive licensing agent. Based in Japan, the Roland Corporation develops, manufactures and markets electronic musical instruments and related peripheral products.
The agreement constitutes the 50th licensee of MMP technologies, a major milestone. "The caliber of global technology companies that have made the decision to purchase an MMP(TM) license is indeed impressive," said Rick Goerner, Patriot Scientific President and CEO.
Fifty global companies from the U.S., Japan, Korea, Taiwan and Europe have purchased MMP Portfolio licenses, including industry leaders such as Hewlett Packard, Kenwood, Sony, Robert Bosch, Philips, Nokia, DirecTV and Fujitsu. "The expanding list of customers using MMP Portfolio design techniques further validates the importance of the MMP Portfolio in leading product applications," Mr. Goerner said.
The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs. These patents are fundamental to dozens of microprocessor-based key features and benefits in contemporary consumer and commercial products ranging from DVD players, mobile phones and portable music players to automobile systems, communications infrastructure and medical equipment.
About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation. The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.
About Roland Corporation
Roland Corporation is a leading manufacturer and distributor of electronic musical instruments, including keyboards and synthesizers, guitar products, electronic percussion, digital recording equipment, amplifiers, audio processors, and multimedia products. With over 35 years of musical instrument development, Roland sets the standard in music technology for the world to follow. For more information,visit http://www.RolandUS.com.
About Patriot Scientific Corporation
Headquartered in Carlsbad, California, Patriot Scientific Corporation is a leading intellectual-property licensing company that developed key microprocessor technologies used in myriad wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more. Patriot Scientific has recently embarked on an aggressive business expansion initiative based on selective expansion of its IP portfolio, minority investments in early-stage technology companies and full M&A. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
SOURCE: Patriot Scientific Corp.